canada africa partner reservation An American man who underwent a pig kidney transplant for the first time dies at the age of 62

An American man who underwent a pig kidney transplant for the first time dies at the age of 62


62-year-old Weymouth, Massachusetts, resident Richard Slayman, who became famous for receiving the world’s first genetically modified pig kidney transplant in March, has died.

In announcing Slayman’s death, the family thanked doctors and the entire care team at Massachusetts General Hospital, ABC News reported.

Earlier in March, Slayman underwent a successful four-hour surgery at Massachusetts General Hospital and was later released in April. However, the reason for his death remains unknown and the hospital confirmed that it was not related to the transplant.

READ ALSO: American man who received the first pig heart transplant dies after two months

“The Mass General transplant team is deeply saddened by the sudden passing of Mr. Rick Slayman. We have no indication that this was the result of his recent transplant.” ABC news quoted the statement from Massachusetts General Hospital.

According to details, before receiving the transplant, Slayman had battled type 2 diabetes and high blood pressure for years. He also relied on dialysis for years before receiving a human kidney transplant in December 2018, which was performed by the same team at Massachusetts General Hospital.

However, the transplanted kidney from the human donor showed rejection symptoms and he returned to dialysis treatment in 2023.

“Mr. Slayman will forever be seen as a beacon of hope for countless transplant patients around the world and we are deeply grateful for his trust and willingness to advance the field of xenotransplantation. “We extend our sincere condolences to Mr. Slayman’s family and loved ones as they remember an extraordinary person whose generosity and kindness touched all who knew him,” the hospital statement said.

READ ALSO: ICMR issues dietary guidelines for Indians, says ‘avoid’ protein supplements

But in March, Slayman underwent another kidney transplant that came from eGenesis, a Cambridge-based pharmaceutical company. It was harvested from a pig that had been genetically modified using CRISPR-Cas9 technology.

The Massachusetts General Hospital said they removed incompatible pig genes and introduced specific human genes to improve compatibility with the recipient’s body, but after seven weeks he died.

What family said:

Slayman’s family expressed their deepest appreciation to the physicians and others at Massachusetts General Hospital.

“Our family is deeply saddened by the sudden passing of our beloved Rick, but takes comfort in knowing that he inspired so many. Millions of people around the world have come to know Rick’s story. We felt – and still feel – comforted by the optimism he desperately gave patients. waiting for a transplant.”

READ ALSO: In a ‘potential miracle’, a pig kidney works in a human patient

“We are extremely grateful to his care team at Massachusetts General Hospital and Mass General Brigham, especially Dr. Williams, Dr. Kawai and Dr. Riella, who did absolutely everything they could to give Rick a second chance. Their tremendous efforts to direct the xenotransplant gave our family seven more weeks with Rick, and the memories we made during that time will remain in our minds and hearts.”

The family added, “Rick achieved that goal and his hope and optimism will live on forever. His legacy will be one that inspires patients, researchers and healthcare professionals everywhere.”

Unlock a world of benefits! From insightful newsletters to real-time inventory tracking, breaking news and a personalized news feed – it’s all here, just a click away! Log in now!